| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Revenue | $1.98B | — |
| Cost of Revenue | $1.15B | — |
| Gross Profit | $827.1M | — |
| R&D Expense | $115.7M | — |
| SG&A Expense | $566.8M | — |
| Operating Income | $90.2M | — |
| Interest Expense | $228.3M | — |
| Pre-tax Income | $614.5M | — |
| Income Tax | $137.9M | — |
| Net Income | $477.9M | +128.6% |
| EPS (Basic) | $24.26 | — |
| EPS (Diluted) | $24.17 | — |
| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $382.6M | +45.6% |
| Accounts Receivable | $395.3M | +4.7% |
| Inventory | $664.9M | -32.3% |
| Current Assets | $1.63B | -7.5% |
| Total Assets | $3.30B | -11.5% |
| Current Liabilities | $431.4M | -13.9% |
| Long-term Debt | $909.5M | -44.6% |
| Line Item | 2024-12-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $160.7M | — |
| Capital Expenditures | $113.2M | — |
| Investing Cash Flow | $790.5M | — |
| Financing Cash Flow | -$846.4M | — |
| Free Cash Flow | $47.5M | — |
| Total Liabilities |
| $1.66B |
| -35.6% |
| Stockholders' Equity | $1.65B | +41.9% |